WallStSmart

Colgate-Palmolive Company (CL)vsMagnera Corp placeholder (MAGN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 537% more annual revenue ($20.80B vs $3.27B). CL leads profitability with a 10.0% profit margin vs -3.4%. CL appears more attractively valued with a PEG of 1.58. CL earns a higher WallStSmart Score of 58/100 (C).

CL

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 8.5Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: 4.21

MAGN

Hold

41

out of 100

Grade: D

Growth: 5.3Profit: 3.0Value: 4.0Quality: 5.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLUndervalued (+10.1%)

Margin of Safety

+10.1%

Fair Value

$98.54

Current Price

$88.58

$9.96 discount

UndervaluedFair: $98.54Overvalued

Intrinsic value data unavailable for MAGN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CL4 strengths · Avg: 9.3/10
Return on EquityProfitability
36.4%10/10

Every $100 of equity generates 36 in profit

Altman Z-ScoreHealth
4.2110/10

Safe zone — low bankruptcy risk

Market CapQuality
$70.63B9/10

Large-cap with strong market position

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

MAGN1 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Areas to Watch

CL4 concerns · Avg: 3.0/10
PEG RatioValuation
1.584/10

Expensive relative to growth rate

P/E RatioValuation
34.2x4/10

Premium valuation, high expectations priced in

Price/BookValuation
492.1x2/10

Trading at 492.1x book value

EPS GrowthGrowth
-5.9%2/10

Earnings declined 5.9%

MAGN4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$399.43M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
4.2%3/10

Operating margin of 4.2%

Debt/EquityHealth
1.893/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Altman Z-Score, Market Cap.

Bull Case : MAGN

The strongest argument for MAGN centers on Price/Book.

Bear Case : CL

The primary concerns for CL are PEG Ratio, P/E Ratio, Price/Book. Debt-to-equity of 54.99 is elevated, increasing financial risk.

Bear Case : MAGN

The primary concerns for MAGN are EPS Growth, Market Cap, Operating Margin. Debt-to-equity of 1.89 is elevated, increasing financial risk.

Key Dynamics to Monitor

CL profiles as a value stock while MAGN is a turnaround play — different risk/reward profiles.

CL is growing revenue faster at 8.4% — sustainability is the question.

CL generates stronger free cash flow (609M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CL scores higher overall (58/100 vs 41/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

Magnera Corp placeholder

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Magnera Corp (MAGN) is a leading technology firm dedicated to pioneering advanced data analytics and machine learning solutions, playing a vital role in the digital transformation of various sectors. The company's strategic emphasis on operational efficiency is backed by a diverse portfolio of proprietary technologies, reflecting its strong commitment to research and development. Magnera Corp's innovative approach and adaptability not only position it favorably within the technology landscape, but also present an attractive investment opportunity for institutional investors aiming to capitalize on transformative growth trends.

Want to dig deeper into these stocks?